Table 3 Complications, treatments, outcomes and survival of the pyogenic liver abscess patients with diabetes mellitus and non-diabetes mellitus
Variables | Median (range)/n (percentage) | Diabetes mellitus | Non-diabetes mellitus | p value |
|---|---|---|---|---|
Complications | ||||
 Bile leakage | 9 (3.96%) | 2 (3.28%) | 7 (4.22%) | 1.000 |
 Intraperitoneal bleeding | 10 (4.41%) | 3 (4.92%) | 7 (4.22%) | 0.731 |
 Plumonary infection | 5 (2.20%) | 2 (3.28%) | 3 (1.81%) | 0.613 |
 Pleural effusion | 51 (18.41) | 17 (27.87%) | 34 (20.48%) | 0.237 |
 Celiac effusion | 21 (7.58) | 8 (13.11%) | 13 (7.83%) | 0.208 |
Treatments | ||||
 Percutaneous drainage | 136 (59.91%) | 29 (47.54%) | 107 (64.46%) | 0.024 |
 Surgical drainage | 28 (12.33%) | 7 (11.48%) | 21 (12.65%) | |
 Conservative treatment | 63 (27.75%) | 25 (40.98%) | 38 (22.89%) | |
Antibiotic use | ||||
 Combined | 125 (55.07%) | 37 (60.66%) | 88 (53.01%) | 0.305 |
 Single | 102 (44.93%) | 24 (39.34%) | 78 (46.99%) | |
Outcomes | ||||
 Cured | 155 (68.28%) | 45 (73.77%) | 110 (66.27%) | 0.282 |
 Improved | 72 (31.72%) | 16 (26.23%) | 56 (33.73%) | |
 Death | 0 (0%) | 0 (0%) | 0 (0%) | |
Hospital stay (days) | 14 (2–52) | 15 (3–40) | 14 (2–52) | 0.444 |
Total hospitalization expenses (×  1000 dollars) | 4.10 (0.39–27.16) | 4.24 (0.39–27.16) | 4.05 (0.47–18.05) | 0.748 |
Reoccurrence in three months | 14 (6.17%) | 6 (9.84%) | 8 (21.05%) | 0.164 |
Survival/Death in six months | 203 (89.43%) /24 (10.57%) | 50 (81.97%) /11 (18.03%) | 153 (92.17%) /13 (7.83%) | 0.027 |